References
- Otto CM. Textbook of clinical echocardiography e-book. Philadelphia: Elsevier Health Sciences; 2013.
- Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–409.
- Fratz S, Janello C, Müller D, et al. The functional right ventricle and tricuspid regurgitation in Ebstein's anomaly. Int J Cardiol. 2013;167(1):258–261.
- Dreyfus GD, Martin RP, Chan KJ, et al. Functional tricuspid regurgitation: a need to revise our understanding. J Am Coll Cardiol. 2015;65(21):2331–2336.
- Koelling TM, Aaronson KD, Cody RJ, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002;144(3):524–529.
- Wiechec M, Nocun A, Wiercinska E, et al. First trimester tricuspid regurgitation and fetal abnormalities. J Perinat Med. 2015;43(5):597–603.
- Falcon O, Faiola S, Huggon I, et al. Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6 week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol. 2006;27(6):609–612.
- Geipel A, Willruth A, Vieten J, et al. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester. Ultrasound Obstet Gynecol. 2010;35(5):535–539.
- Pereira S, Ganapathy R, Syngelaki A, et al. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol. 2011;117(6):1384–1391.
- Carvalho JS, Allan LD, Chaoui R, et al. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol. 2013;41(3):348–359.
- Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–1463.
- Falcon O, Auer M, Gerovassili A, et al. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol. 2006;27(2):151–155.
- Chu C, Yan Y, Ren Y, et al. Prenatal diagnosis of congenital heart diseases by foetal echocardiography in second trimester: a Chinese multicenter study. Acta Obstet Gynecol Scand. 2017;96(4):454–463.
- McElhinney DB, Marshall AC, Wilkins-Haug LE, et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation. 2009;120(15):1482–1490.
- Firpo C, Hoffman JI, Silverman NH. Evaluation of fetal heart dimensions from 12 weeks to term. Am J Cardiology. 2001;87(5):594–600.
- Tan J, Silverman NH, Hoffman JI, et al. Cardiac dimensions determined by cross-sectional echocardiography in the normal human fetus from 18 weeks to term. Am J Cardiology. 1992;70(18):1459–1467.
- Kagan KO, Valencia C, Livanos P, et al. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation. Ultrasound Obstet Gynecol. 2009;33(1):18–22.
- Gembruch U, Smrcek JM. The prevalence and clinical significance of tricuspid valve regurgitation in normally grown fetuses and those with intrauterine growth retardation. Ultrasound Obstet Gynecol. 1997;9(6):374–382.
- Respondek ML, Kammermeier M, Ludomirsky A, et al. The prevalence and clinical significance of fetal tricuspid valve regurgitation with normal heart anatomy. Am J Obstet Gynecol. 1994;171(5):1265–1270.
- Huggon IC, DeFigueiredo DB, Allan LD. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11–14 weeks of gestation. Heart. 2003;89(9):1071–1073.
- Messing B, Porat S, Imbar T, et al. Mild tricuspid regurgitation: a benign fetal finding at various stages of pregnancy. Ultrasound Obstet Gynecol. 2005;26(6):606–610.
- Nathan AT, Marino BS, Dominguez T, et al. Tricuspid valve dysplasia with severe tricuspid regurgitation: fetal pulmonary artery size predicts lung viability in the presence of small lung volumes. Fetal Diagn Ther. 2010;27(2):101–105.
- Tsukimori K, Morihana E, Fusazaki N, et al. Critical Ebstein anomaly in a fetus successfully managed by elective preterm delivery and surgical intervention without delay after birth. Pediatr Cardiol. 2012;33(2):343–346.
- Andrews RA, Tibby SM, Sharland GK, et al. Prediction of outcome of tricuspid valve malformations diagnosed during fetal life. Am J Cardiology. 2008; 101(7):1046–1050.
- Freud LR, Escobar-Diaz MC, Kalish BT, et al. Outcomes and predictors of perinatal mortality in fetuses with Ebstein anomaly or tricuspid valve dysplasia in the current era: a multicenter study. Circulation. 2015;132(6):481–489.
- Volpe P, De Robertis V, Campobasso G, et al. Diagnosis of congenital heart disease by early and second-trimester fetal echocardiography. J Ultrasound Med. 2012;31(4):563–568.
- Cruz-Lemini M, Crispi F, Valenzuela-Alcaraz B, et al. Fetal cardiovascular remodeling persists at 6 months in infants with intrauterine growth restriction. Ultrasound Obstet Gynecol. 2016;48(3):349–356.